共 270 条
[1]
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]
Bray F(2014)Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers Br J Surg 101 321-338
[3]
Siegel RL(2013)Oesophageal carcinoma Lancet 381 400-412
[4]
Ferlay J(2010)Comparison of the 6th and 7th editions of the American joint committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma Ann Thorac Surg 89 1024-1031
[5]
Lortet-Tieulent J(2018)Neoadjuvant Chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical Trial J Clin Oncol 36 2796-2803
[6]
Jemal A(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2074-2084
[7]
Kumagai K(2015)Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Lancet Oncol 16 1090-1098
[8]
Rouvelas I(2010)Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma World J Gastroenterol 16 1649-1654
[9]
Tsai JA(2014)Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901 J Clin Oncol 32 2416-2422
[10]
Mariosa D(2005)Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 659-668